Wim E. M. Mol
Director/Board Member at Inorbit Therapeutics AB
Network origin in Wim E. M. Mol first degree
Entity | Entity type | Industry | |
---|---|---|---|
Inorbit Therapeutics AB
Inorbit Therapeutics AB Pharmaceuticals: MajorHealth Technology Inorbit Therapeutics AB discovers and develops small molecule therapeutics based on molecules with proven clinical efficacy in humans. The company was founded in 2015 and is headquartered in Moelndal, Sweden.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Wim E. M. Mol via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Entreprenörskapital i Sverige AB
Entreprenörskapital i Sverige AB Investment Banks/BrokersFinance Entreprenörskapital i Sverige AB provides activities of securities and commodity brokers. It attracts companies to support companies in a start-up phase. It is the products of the collective wealth of risk capital experience. It desires to explore new approaches to investing in unlisted companies. It delivers benefits to investors, entrepreneurs, customers, and society. The company was founded by Raymond Peter Wendel on January 12, 2011 and is headquartered in Gothenburg, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Improve Tec Hönö AB | Chairman | ||
University of Bern | College/University | Doctorate Degree | |
MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
Nanolyze AB
Nanolyze AB Miscellaneous Commercial ServicesCommercial Services Nanolyze AB develops bio analytical technology. The company is based in Mölndal, Sweden. Nils Löfgren has been the CEO of the Swedish company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Life Genomics AB
Life Genomics AB Medical/Nursing ServicesHealth Services Life Genomics AB provides biochemical, biotechnical, genetic, and medical analysis, screening, and diagnostic. Its product, Harmony NIPT test, tests the fetus’ DNA for Down syndrome. The company was founded by Mikael Kubista in 2014 and is headquartered in Gothenburg, Sweden. | Medical/Nursing Services | Director/Board Member | |
Almi Invest AB
Almi Invest AB Investment ManagersFinance Almi Invest AB (Almi) is a Venture Capital subsidiary of ALMI Företagspartner AB, founded in 2009. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor | |
Lennart ekerholms stiftelse | Investment Trusts/Mutual Funds | Director/Board Member | |
RGNT Electric AB
RGNT Electric AB Motor VehiclesConsumer Durables RGNT Electric AB is a Swedish company that specializes in electric motorcycles. The company is based in Kungsbacka, Sweden. The company's range of motorbikes is both timeless and forward-thinking. RGNT Electric was founded in 2019 by Jonathan Åström. Göran Karlsson has been the CEO of the company since January 12, 2023. | Motor Vehicles | Director/Board Member | |
HOODIN AB | Packaged Software | Director/Board Member | |
Ancoria Insurance Ltd.
Ancoria Insurance Ltd. Multi-Line InsuranceFinance Ancoria Insurance Ltd. provides insurance services. It offers life insurance policies and occupational pension schemes. The company was founded by Sievert Larsson in 1987 and is headquartered in Nicosia, Cyprus. | Multi-Line Insurance | Director/Board Member | |
ECTIN RESEARCH AB | Biotechnology | Chairman | |
SP HMSO Göteborg AB | Director/Board Member | ||
O Mgmt AB | Corporate Officer/Principal | ||
Handelshögskolan i Göteborg | College/University | Graduate Degree | |
ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member | |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member | |
IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
AbbVie AG | Corporate Officer/Principal |
Statistics
International
Sweden | 17 |
Switzerland | 4 |
Cyprus | 2 |
Sectoral
Health Technology | 7 |
Finance | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Health Services | 2 |
Operational
Director/Board Member | 16 |
Independent Dir/Board Member | 4 |
Chairman | 4 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 2 |
Most connected contacts
Insiders | |
---|---|
Hans-Peter Albert Ostler | 15 |
Louise Warme | 4 |
Dominik Höchli | 4 |
Johannes Bruski | 1 |
Bert Benthem | 1 |
- Stock Market
- Insiders
- Wim E. M. Mol
- Company connections